Navigation Links
Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes
Date:12/2/2008

Randomized Comparator Study to Evaluate Efficacy of Commercially Available Hypomethylating Agents

WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswire/ -- Eisai Corporation of North America today announced that it plans to initiate the first clinical trial evaluating the activity of Dacogen(R) (decitabine for injection) compared to Vidaza(R) (azacitidine) in adult patients with intermediate-1, intermediate-2 or high-risk myelodysplastic syndromes (MDS), a potentially life-threatening group of bone marrow diseases that limit the production of functional blood cells. The head-to-head trial will be conducted in the United States and will directly compare Dacogen(R) to Vidaza(R) with a primary endpoint of complete response rate (including marrow complete response).

"Previous to the introduction of the hypomethylating agents, supportive care was the only treatment option for patients living with MDS," said Dr. Hagop M. Kantarjian, chairman of the Leukemia Department and professor of medicine, University of Texas M.D. Anderson Cancer Center. "This study, for the first time, will provide physicians with important information to understand how these two agents compare when treating patients with MDS, who currently have a generally poor prognosis, with life expectancies shorter than those with lung cancer."

Study Design

This randomized, multi-center, open-label study will be conducted among 228 adult patients with intermediate-1, intermediate-2 and high-risk MDS. Patients will be randomized on a 1:1 ratio to either Dacogen(R) or Vidaza(R). Each treatment arm will be stratified by IPSS risk group and type of MDS (primary vs. secondary).

The study's primary objective is to compare the complete response rates, including bone marrow response rates, for Dacogen(R) versus Vidaza(R).

"Findings from this trial could help clarify the fundament
'/>"/>

SOURCE Eisai Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
2. Eisai Inc. and the Alzheimers Association Introduce the C.A.R.E. Pharmacy Award and Call for Nominations
3. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
4. Eisai Inc. Supports Acting Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
5. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
6. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
7. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
8. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
9. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
10. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 The Woodstock Fruit Festival is proud ... Festival this summer, which will be held in Diamond Point, ... , Blake professes the benefits he's received by regularly ... fuel his world class sprinting abilities. Fruit is commonly considered ... drawing attention. "Yohan Blake believes in the power of natural ...
(Date:6/17/2013)... 2013 MelanSol® All Natural Skin Care ... the US distributor for MelanSol®, has partnered with the ... Food Bank to support their efforts to feed ... that they receive a portion of every sale of ... Moisturizer. Contributions will be given on sales from ...
(Date:6/17/2013)... A team from the New York Stem Cell ... Center of Columbia University has generated patient-specific beta cells, ... maturity-onset diabetes of the young (MODY). , The ... induced pluripotent stem (iPS) cells, from which they then ... cell-derived beta cells secreted insulin in a manner similar ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a ... has recently undergone a mainstream culture explosion. Interpretation of the ... Surgery, they regard the term to mean a combination of ... of the effects of pregnancy on a woman’s body. ... the breast with gain or loss of volume, widening of ...
(Date:6/17/2013)... pyrvinium pamoate inhibits aggressive forms of prostate cancer that ... conducted in an animal model. The results will be ... in San Francisco. , "Our novel prostate cancer drug ... lead author Jeremy Jones, PhD, assistant professor of molecular ... Duarte, CA. "Thus, it has the potential to treat ...
Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2
... has passed a resolution that from now on all ... the pathogen, Enterobacter sakazakii. ,These strong warning ... label proclaiming mother’s milk as the best for infants. ... reported by consumption of contaminated baby formula. A French ...
... H5N1 has mutated since 2002 to become more dangerous ... ,The Asian strain H5N1 influenza virus has changed its ... to ducks; the virus multiplies in the ducks without infecting ... duck Waterfowl is a natural host for H5N1 influenza virus, ...
... be responsible for birth defects, cancer and other health ... used genetically modified mice to see how the microRNAs ... the mice were grown without the microRNA molecules they ... ,MicroRNA (miRNA) are small RNA molecules that control the ...
... new study presented at the Annual Congress for Dermatological Research ... marketed by Paris-based IsoCell Nutra, significantly increased the levels of ... that SOD has a different mode of action to vitamins. ... discovered in 1968, it is the first antioxidant mobilized by ...
... noticed in women consuming a diet rich in calcium and ... at the University of Massachusetts at Amherst conducted the study. ... who participated in the Nurse Health Study II and developed ... not develop PMS. This data was analysed and interpreted., ...
... two months of previous prescription of antibiotics increases //the ... than in people who were given antibiotics after almost ... levels of taking antibiotics are harmful to health as ... is the first study that assesses the risk to ...
Cached Medicine News:Health News:Influenza Avian Flu strain has become more contagious and dangerous. , 2Health News:Influenza Avian Flu strain has become more contagious and dangerous. , 3Health News:New Supplement Found To Be Effective Against Sunburn 2
(Date:6/17/2013)... , June 17, 2013 ... promoted through new ,Wake-Up Call, campaign and ICD-10 ... a world-leading provider of scientific, technical and medical ... of EduCode ® Doc Briefs , ... other practitioners. EduCode Doc Briefs is available on ...
(Date:6/17/2013)... June 17, 2013  The American Society of ... report on the effectiveness of medications for opioid ... FDA-approved drugs by many state governments and insurance ... drunk driving car crashes, an epidemic led by ... heroin. Yet, safe and effective medications to treat ...
(Date:6/17/2013)... -- The law firm of Rheingold, Valet, Rheingold, McCartney & ... the first suit in New York ... two common anti-diabetic drugs, Byetta and Janumet (also known as ... resident Robert Cataletto , was filed on June 14, ... 13-3411. Mr. Cataletto received prescriptions from the doctor ...
Breaking Medicine Technology:Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 2Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 3Effective Rx thwarted for deadly opiate epidemic 2Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: